+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
TRAIL Receptor 2 Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

TRAIL Receptor 2 Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-myc Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 96 Pages
  • Global
From
From
LAG-3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
AXL Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

AXL Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
TIGIT Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

TIGIT Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CD47 Antigen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

CD47 Antigen Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CD137 Agonist Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

CD137 Agonist Antibody - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TIL Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

TIL Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Hepatocellular Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Thymic Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Thymic Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cutaneous Squamous Cell Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous Squamous Cell Carcinoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 120 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 230 Pages
  • Global
From
Oligodendroglioma - Pipeline Insight, 2025 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-CD40 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD40 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Metastatic Liver Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Liver Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Neuroblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Nasopharyngeal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Nasopharyngeal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more